New drug controls stubborn high blood pressure

A new drug, baxdrostat, shows promise as a "gamechanger" for patients with difficult-to-control high blood pressure. Trials demonstrated significant blood pressure reductions in individuals resistant to existing treatments, potentially impacting half a billion people globally. The drug targets aldosterone, a hormone linked to hypertension, marking a scientific breakthrough after decades of research.